Rallybio Corp
RLYB
Get informed when a big investor buys or sells
+ FollowMarket Cap$92.8M
Close$
$6.92
56.3% downside
Current Fair Value
56.3% downsideOvervalued by 56.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $92.80 Million |
|---|---|
| Enterprise Value | $51.66 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | -0.88 |
| Outstanding Shares | 5,688,584 |
Return
| Return on Equity | -15.55% |
|---|---|
| Return on Assets | -14.35% |
| Return on Invested Capital | -55.88% |
Valuation & Multiples
| P/E Ratio | -10.74 |
|---|---|
| PEG | 87.3 |
| Price to Sales | - |
| Price to Book Ratio | 1.98 |
| Enterprise Value to Revenue | 60.2 |
| Enterprise Value to EBIT | -1.84 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-1.20
Average shareholder expectationRevenue Estimate
$212,000
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-1.28
Average shareholder expectationRevenue Estimate
$216,480
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.03%▲ 23.07% |
|---|---|
| Total Invested | $41.85M▲ 101.87% |
| Investors Holding | 38▼ 7.00% |
ESG Score
No data
About Rallybio Corp
2,021 employees